Goldberg J - Search Results

1

Pentostatin increases the acute toxicity of high dose cyclophosphamide.

Gryn J, Gordon R, Bapat A, Goldman N, Goldberg J. Gryn J, et al. Among authors: goldberg j. Bone Marrow Transplant. 1993 Sep;12(3):217-20. Bone Marrow Transplant. 1993. PMID: 8241979

2

The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.

Gryn J, Johnson E, Goldman N, Devereux L, Grana G, Hageboutros A, Fernandez E, Constantinou C, Harrer W, Viner E, Goldberg J. Gryn J, et al. Among authors: goldberg j. Bone Marrow Transplant. 1997 Feb;19(3):221-6. doi: 10.1038/sj.bmt.1700646. Bone Marrow Transplant. 1997. PMID: 9028549

3

Propranolol for the treatment of cyclosporine-induced headaches.

Gryn J, Goldberg J, Viner E. Gryn J, et al. Among authors: goldberg j. Bone Marrow Transplant. 1992 Mar;9(3):211-2. Bone Marrow Transplant. 1992. PMID: 1511258

4

Mitoxantrone and 5-azacytidine for refractory/relapsed ANLL or CML in blast crisis: a leukemia intergroup study.

Goldberg J, Gryn J, Raza A, Bennett J, Browman G, Bryant J, Grunwald H, Larson R, Vogler R, Preisler H. Goldberg J, et al. Am J Hematol. 1993 Aug;43(4):286-90. doi: 10.1002/ajh.2830430411. Am J Hematol. 1993. PMID: 7690519 Clinical Trial.

5

The toxicity of daily inhaled amphotericin B.

Gryn J, Goldberg J, Johnson E, Siegel J, Inzerillo J. Gryn J, et al. Among authors: goldberg j. Am J Clin Oncol. 1993 Feb;16(1):43-6. doi: 10.1097/00000421-199302000-00011. Am J Clin Oncol. 1993. PMID: 8424403

6

The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup study.

Larson RA, Day RS, Azarnia N, Bennett JM, Browman G, Goldberg J, Gottlieb A, Grunwald H, Miller K, Raza A, et al. Larson RA, et al. Among authors: goldberg j. Br J Haematol. 1992 Oct;82(2):337-46. doi: 10.1111/j.1365-2141.1992.tb06427.x. Br J Haematol. 1992. PMID: 1419816 Clinical Trial.

7

Cell-cycle characteristics - alterable determinants of remission duration in a study of 179 standard risk newly diagnosed patients with acute myeloid-leukemia.

Raza A, Yousuf N, Bokhari S, Abbas A, Lampkin B, Pancoast J, Bismayer J, Siegrist C, Browman G, Bennett J, Goldberg J, Grunwald H, Larson R, Tricot G, Vogler R, Gartside P, Preisler H. Raza A, et al. Among authors: goldberg j. Int J Oncol. 1993 Feb;2(2):301-7. doi: 10.3892/ijo.2.2.301. Int J Oncol. 1993. PMID: 21573555

8

Limited efficacy of a four-day course of high-dose cytosine arabinoside in the treatment of poor-risk patients with acute nonlymphocytic leukemia.

Preisler HD, Raza A, Larson R, Browman G, Goldberg J, Grunwald H, Vogler R, Bennett J, Gottlieb A, D'Arrigo P. Preisler HD, et al. Among authors: goldberg j. Cancer Chemother Pharmacol. 1986;18(3):257-60. doi: 10.1007/BF00273398. Cancer Chemother Pharmacol. 1986. PMID: 3802381

9

Infectious complications of bone marrow transplantation.

Silber JL, Goldberg J. Silber JL, et al. Among authors: goldberg j. N J Med. 1993 Apr;90(4):303-6. N J Med. 1993. PMID: 8506092

10

Randomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a Leukemia Intergroup Study.

Vogler WR, Preisler HD, Winton EF, Gottlieb AJ, Goldberg J, Brennan J, Grunwald H, Rai K, Browman G, Miller KB, et al. Vogler WR, et al. Among authors: goldberg j. Cancer Treat Rep. 1986 Apr;70(4):455-9. Cancer Treat Rep. 1986. PMID: 3516395 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,267 results

Search Page